Rapid Dose Therapeutics (XCNQ:DOSE) Net Margin % : -419.23% (As of Nov. 2023)

Rapid Dose Therapeutics Net Margin % Chart

Rapid Dose Therapeutics Annual Data
	Trend	Sep14	Sep15	Sep16	Sep17	Sep18	Feb19	Feb20	Feb21	Feb22	Feb23
Net Margin %		Get a 7-Day Free Trial					-	-7,886.14	-239.07	-484.42	-530.64

Rapid Dose Therapeutics Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Net Margin %	Get a 7-Day Free Trial															-190.85	-600.92	-235.27	-207.08	-419.23

Competitive Comparison of Rapid Dose Therapeutics's Net Margin %

For the Biotechnology subindustry, Rapid Dose Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's Net Margin % falls into.

Rapid Dose Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Rapid Dose Therapeutics's Net Margin for the fiscal year that ended in Feb. 2023 is calculated as

Rapid Dose Therapeutics's Net Margin for the quarter that ended in Nov. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Dose Therapeutics  (XCNQ:DOSE) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Rapid Dose Therapeutics Net Margin % Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics (XCNQ:DOSE) Business Description